Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-11

Clinical Trial Update: EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization [Phase 4]

View source ↗

Summary

This Phase 4 study (EXCLAIM) evaluated extended prophylaxis for venous thromboembolism in acutely ill medical patients with prolonged immobilization; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lovenox (enoxaparin)

Snippet

Sponsor: Sanofi | Conditions: Venous Thromboembolism | Phase 4 | Status: COMPLETED